![Foto de María Ángeles](/img/nophoto.png)
María Ángeles
Serrano García
Catedrática de Universidad
Publicaciones (101) Publicaciones de María Ángeles Serrano García
2022
-
La Sociedad Española de Bioquímica y Biología Molecular: objetivos y desafíos
Encuentros multidisciplinares, Vol. 24, Núm. 71
-
Los beneficios de obtener sellos internacionales de calidad para enseñanzas universitarias argentinas, chilenas, ecuatorianas, españolas y mexicanas
Revista Iberoamericana de Educación, Vol. 88, Núm. 1, pp. 49-66
2021
-
Auditorías virtuales en el Programa de Sellos Internacionales de Calidad (SIC) de ANECA en tiempos de pandemia
RIED: revista iberoamericana de educación a distancia, Vol. 24, Núm. 2, pp. 245-261
-
Cuatro universidades españolas participarán en el proyecto piloto (2021-2022) del sello de la Federación Mundial de Educación Médica (WFME) gestionado por la Agencia Nacional de Evaluación de la Calidad y Acreditación (ANECA)
FEM. Revista de la Fundación Educación Médica, Vol. 24, Núm. 3, pp. 109-111
2020
-
Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5
-
Role of genetic variations in the hepatic handling of drugs
International Journal of Molecular Sciences, Vol. 21, Núm. 8
2019
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2018
-
Chemoprotective Role of Vitamin C in Liver Diseases
The Liver: Oxidative Stress and Dietary Antioxidants (Elsevier), pp. 139-153
-
Chemoresistance and chemosensitization in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453
-
Genetic heterogeneity of SLC22 family of transporters in drug disposition
Journal of Personalized Medicine, Vol. 8, Núm. 2
-
Molecular bases of the poor response of liver cancer to chemotherapy
Clinics and Research in Hepatology and Gastroenterology
2017
-
Molecular bases of chemoresistance in cholangiocarcinoma
Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900
2016
-
Protective role of biliverdin against bile acid-induced oxidative stress in liver cells
Free Radical Biology and Medicine, Vol. 97, pp. 466-477
2014
-
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10
2013
-
Genetic Variants Involved in Intracellular Mechanisms of Chemoresistance to Anticancer Drugs Due to Changes in the Effect on Their Molecular Targets
eLS
-
Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 14, pp. 4432-4441
2012
-
Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins
Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704
-
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427
2011
-
A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis
Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225